3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
18F-S2P PET Imaging in the Evaluation of Large Artery AtherosclerosisEmbolism, Embolism and Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorderNot yet recruitingNot applicable2026-09-11NCT07815860
Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLCKRAS G12C Mutation; Neoadjuvant Therapy; Resectable NSCLC; Stage IB-IIIA NSCLCRecruitingPhase 22026-03-25NCT07492342
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ETHemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis diseaseRecruitingPhase 22025-11-17NCT06552429